(Q30771917)

26 June 2017

title

Recombinant antibodies for cancer diagnosis and therapy (English)

1 reference

26 June 2017

1 reference

1 reference

Hudson PJ

1

1 reference

26 June 2017

Souriau C

series ordinal

2

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Expert Opinion on Biological Therapy

26 June 2017

published in

1 reference

26 June 2017

volume

1

1 reference

26 June 2017

issue

5

1 reference

26 June 2017

page(s)

845-855

1 reference

Of mice and men: hybridoma and recombinant antibodies

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Recombinant antibodies: a novel approach to cancer diagnosis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Antibody engineering and its applications in tumor targeting and intracellular immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Antibodies in diagnostics - from immunoassays to protein chips

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Homodimers but not monomers of Rituxan (chimeric anti-CD20) induce apoptosis in human B-lymphoma cells and synergize with a chemotherapeutic agent and an immunotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Design and application of diabodies, triabodies and tetrabodies for cancer targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Nucleotide binding and autophosphorylation of the clock protein KaiC as a circadian timing process of cyanobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Methods for generating multivalent and bispecific antibody fragments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Numerical selection of optimal tumor imaging agents with application to engineered antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Renal metabolism of 3'-iodohippuryl N(epsilon)-maleoyl-L-lysine (HML)-conjugated Fab fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Bispecific human IgG by design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

A new model for intermediate molecular weight recombinant bispecific and trispecific antibodies by efficient heterodimerization of single chain variable domains through fusion to a Fab-chain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Local immunotherapy of glioma patients with a combination of 2 bispecific antibody fragments and resting autologous lymphocytes: evidence for in situ t-cell activation and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Development and applications of surface-linked single chain antibodies against T-cell antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Targeting of adenoviral vectors through a bispecific single-chain antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Isolation of new anti-CD30 scFvs from DNA-immunized mice by phage display and biologic activity of recombinant immunotoxins produced by fusion with truncated pseudomonas exotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Blue-fluorescent antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Clinical applications of phage-derived sFvs and sFv fusion proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Fusion of the tissue factor extracellular domain to a tumour stroma specific single-chain fragment variable antibody results in an antigen-specific coagulation-promoting molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Noninvasive gene targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

The combination of chemotherapy and systemic immunotherapy with soluble B7-immunoglobulin G leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Design and use of phage display libraries for the selection of antibodies and enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Antibodies to human fetal erythroid cells from a nonimmune phage antibody library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Natural and designer binding sites made by phage display technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Baculoviral display of functional scFv and synthetic IgG-binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Selecting and evolving functional proteins in vitro by ribosome display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Picomolar affinity antibodies from a fully synthetic naive library selected and evolved by ribosome display

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Functional proteins from a random-sequence library

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Isolation of anti-angiogenesis antibodies from a large combinatorial repertoire by colony filter screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Flow cytometric screening of cell-based libraries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

High affinity T cell receptors from yeast display libraries block T cell activation by superantigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

By-passing selection: direct screening for antibody-antigen interactions using protein arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Mass spectral analysis of a protein complex using single-chain antibodies selected on a peptide target: applications to functional genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Expression of single-chain Fv-Fc fusions in Pichia pastoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Inhibitory Fc receptors modulate in vivo cytotoxicity against tumor targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Immunoglobulin VH domains and beyond: design and selection of single-domain binding and targeting reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Antigen-binding specificities of antibodies are primarily determined by seven residues of VH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Directed evolution of a stable scaffold for T-cell receptor engineering.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Improved production and function of llama heavy chain antibody fragments by molecular evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

A central core structure in an antibody variable domain determines antigen specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Humanization of a mouse monoclonal antibody neutralizing TNF-alpha by guided selection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Drug targeting to the brain using avidin-biotin technology in the mouse; (blood-brain barrier, monoclonal antibody, transferrin receptor, Alzheimer's disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: an antibody that broadly neutralizes primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.1.5.845

21 January 2018

Identifiers

DOI

10.1517/14712598.1.5.845

1 reference

26 June 2017

1 reference